{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T12:45:27Z","timestamp":1770986727260,"version":"3.50.1"},"reference-count":33,"publisher":"Bentham Science Publishers Ltd.","issue":"7","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMM"],"published-print":{"date-parts":[[2019,8,2]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>The incidence of fungal infections has increased significantly.\nSpecifically the cases of candida albicans infection are increasing day by day and their\nresistance to clinically approved drugs is a major concern for humans. Various classes\nof antifungal drugs are available in the market for the treatment of these infections but\nunfortunately, none of them is able to treat the infection.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>Thus, in the present investigation, we have repurposed the well-known drug\n(Fluvastatin) in the treatment of Candida albicans infections by using in silico, in vitro\nand ex vivo techniques.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Firstly, we developed and validated a simple model of CYP45014\u03b1-lanosterol\ndemethylase of Candida albicans by using crystal structure of Mycobacterium\ntuberculosis (1EA1). Further, fluvastatin was docked with a validated model of\nCYP45014\u03b1-lanosterol demethylase and revealed good binding affinity as that of\nfluconazole. In vitro results (Percentage growth retardation, Fungal growth kinetics,\nBiofilm test and Post antifungal test) have shown good antifungal activity of fluvastatin.\nFinally, the results of MTT assay have shown non-cytotoxic effect of fluvastatin in murine\nsplenocytes and thymocytes.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p> Firstly, we developed and validated a simple model of CYP45014\u03b1-lanosterol\ndemethylase of Candida albicans by using crystal structure of Mycobacterium\ntuberculosis (1EA1). Further, fluvastatin was docked with a validated model of\nCYP45014\u03b1-lanosterol demethylase and revealed good binding affinity as that of\nfluconazole. In vitro results (Percentage growth retardation, Fungal growth kinetics,\nBiofilm test and Post antifungal test) have shown good antifungal activity of fluvastatin.\nFinally, the results of MTT assay have shown non-cytotoxic effect of fluvastatin in murine\nsplenocytes and thymocytes.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>However, further in vivo studies are required to confirm the complete role\nof fluvastatin as an antifungal agent.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1566524019666190520094644","type":"journal-article","created":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T23:47:52Z","timestamp":1558396072000},"page":"506-524","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Repurposing of Fluvastatin Against Candida albicans CYP450 Lanosterol 14 \u03b1-demethylase, a Target Enzyme for Antifungal Therapy: An In silico and In vitro Study"],"prefix":"10.2174","volume":"19","author":[{"given":"Ritika","family":"Rana","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Indo-Soviet Friendship Pharmacy College (ISFCP), Moga, Punjab, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruchika","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Indo-Soviet Friendship College of Professional Studies (ISFCPS), Moga, Punjab, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7806-9986","authenticated-orcid":true,"given":"Anoop","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Indo-Soviet Friendship Pharmacy College (ISFCP), Moga, Punjab, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1469-0691.2001.tb00005.x","volume":"7","author":"Groll A.H.","year":"2001","unstructured":"Groll A.H.; Walsh T.J.;  Uncommon opportunistic fungi new nosocomial threats. Clin Microbiol Infect 2001,7,8-24","journal-title":"Clin Microbiol Infect"},{"key":"ref=2","first-page":"413","volume":"95","author":"Giraldo P.","year":"2000","unstructured":"Giraldo P.; Von Nowakowski A.; Gomes F.A.;  Vaginal colonization by Candida in asymptomatic women with and without a history of recurrent vulvovaginal candidiasis. Obstet Gynecol 2000,95,413-416","journal-title":"Obstet Gynecol"},{"key":"ref=3","unstructured":"Available at  data accessed on\n(2\/4\/18)"},{"key":"ref=4","unstructured":"US Department of Health and Human Services (2012)\nCenters for Disease Control and Prevention (CDC). Antibiotic\nresistance threats in the United States.  Accessed 23 Sept 2015 http:\/\/www.cdc.gov\/drugresistance\/threat-report-2013\/pdf\/ar-threats-2013-508.pdf"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3201\/eid1001.030119","volume":"10","author":"Jabra-Rizk M.A.","year":"2004","unstructured":"Jabra-Rizk M.A.; Falkler W.A.; Meiller T.F.;  Fungal biofilms and drug resistance. Emerg Infect Dis 2004,10,14-19","journal-title":"Emerg Infect Dis"},{"key":"ref=6","author":"Rana R","year":"2018","unstructured":"Rana R; Sharma R; Kumar A.;  Repurposing of Existing\nStatin drugs for treatment of Microbial Infections: How much\npromising?. Infec disord drug targets   2018"},{"key":"ref=7","first-page":"151424","volume":"2009","author":"Schmidt M.","year":"2009","unstructured":"Schmidt M.; Dzogbeta S.; Boyer M.P.;  Inhibition of Candida albicans by Fluvastatin Is dependent on pH. Biochem Res Int 2009,2009,151424","journal-title":"Biochem Res Int"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1099\/0022-1317-51-2-105","volume":"51","author":"Nash J.D.","year":"2002","unstructured":"Nash J.D.; Burgess D.S.; Talbert R.L.;  Effect of fluvastatin and pravastatin, HMG-CoA reductase inhibitors, on fluconazole activity against Candida albicans. Indian J Med Microbiol 2002,51,105-109","journal-title":"Indian J Med Microbiol"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1128\/AAC.41.4.850","volume":"41","author":"Chin N.X.","year":"1997","unstructured":"Chin N.X.; Weitzman I.; Della-Latta P.;  \n                         In vitro  activity of fluvastatin, a cholesterol-lowering agent, and synergy with flucanazole and itraconazole against Candida species and Cryptococcus neoformans. Antimicrob Agents Chemother 1997,41,850-852","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1128\/MMBR.00032-07","volume":"72","author":"Chaffin W.L.","year":"2008","unstructured":"Chaffin W.L.;  Candida albicans cell wall proteins. Microbiol Mol Biol Rev 2008,72,495-544","journal-title":"Microbiol Mol Biol Rev"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1073\/pnas.061562898","volume":"98","author":"Podust L.M.","year":"2001","unstructured":"Podust L.M.; Poulos T.L.; Waterman M.R.;  Crystal structure of cytochrome P450 14\u03b1-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors. Proc Natl Acad Sci USA 2001,98,3068-3073","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/ct700301q","volume":"4","author":"Hess B.","year":"2014","unstructured":"Hess B.; Kutzner C.; Van Der Spoel D.;  GROMACS 4. Algorithms for highly efficient, load-balanced, and scalable molecular simulation. J Chem Theory Comput 2014,4,435-447","journal-title":"J Chem Theory Comput"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.compbiolchem.2018.12.005","volume":"78","author":"Kant K.","year":"2019","unstructured":"Kant K.; Lal U.R.; Kumar A.; Ghosh M.;  A merged molecular docking, ADME-T and dynamics approaches towards the genus of Arisaema as herpes simplex virus type 1 and type 2 inhibitors. Comput Bioland Chem 2019,78,217-226","journal-title":"Comput Bioland Chem"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"8577","DOI":"10.1063\/1.470117","volume":"103","author":"Essmann U.","year":"1995","unstructured":"Essmann U.; Perera L.; Berkowitz M.;  A smooth particle mesh Ewald method. J Phys Chem Biophys 1995,103,8577-8593","journal-title":"J Phys Chem Biophys"},{"key":"ref=15","first-page":"1355","volume":"60","year":"2004","unstructured":"Schu\u00c8ttelkopf AW,Van Aalten DM. PRODRG a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallographica Section D. Acta Crystallogr 2004,60,1355-1363","journal-title":"Acta Crystallogr"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1093\/bioinformatics\/btl461","volume":"22","author":"Grant B.J.","year":"2006","unstructured":"Grant B.J.; Rodrigues A.P.; ElSawy K.M.;  Bio3d: anR package for the comparative analysis of protein structures. BMC Bioinformatics 2006,22,2695-2696","journal-title":"BMC Bioinformatics"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/prot.340170408","volume":"17","author":"Amadei A.","year":"1993","unstructured":"Amadei A.; Linssen A.; Berendsen H.J.;  Essential dynamics of proteins. Proteins: Struct, Funct, Bioinf. Proteins 1993,17,412-425","journal-title":"Proteins"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1103\/PhysRevLett.68.2696","volume":"68","author":"Garc\u00eda A.E.","year":"1992","unstructured":"Garc\u00eda A.E.;  Large-amplitude nonlinear motions in proteins. Phys Rev Lett 1992,68,2696-2700","journal-title":"Phys Rev Lett"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1021\/jp9536920","volume":"100","author":"Balsera M.A.","year":"1996","unstructured":"Balsera M.A.; Wriggers W.; Oono Y.;  Principal component analysis and long time protein dynamics. J Phys Chem B 1996,100,2567-2572","journal-title":"J Phys Chem B"},{"key":"ref=20","unstructured":"Himedialabs.com\/TD\/LQ508.pdf  for tryptone soya broth (data\naccessed on 2\/4\/18)."},{"key":"ref=21","first-page":"1","author":"Gupta M.","year":"2019","unstructured":"Gupta M.; Sharma R.; Kumar A.;  Comparative potential of Simvastatin, Rosuvastatin and Fluvastatin against bacterial infection: an  in silico  and  in vitro  study. Orient Pharm Exp Med 2019,1-17","journal-title":"Orient Pharm Exp Med"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jmii.2012.03.009","volume":"46","author":"Wu W.S.","year":"2013","unstructured":"Wu W.S.; Chen C.C.; Chuang Y.C.;  Efficacy of combination oral antimicrobial agents against biofilm-embedded methicillin-resistant Staphylococcus aureus. J Microbiol Immunol Infect 2013,46,89-95","journal-title":"J Microbiol Immunol Infect"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.pestbp.2015.03.003","volume":"119","author":"Kumar A.","year":"2015","unstructured":"Kumar A.; Sharma N.;  Comparative efficacy of piperine and curcumin in deltamethrin induced splenic apoptosis and altered immune functions. Pestic Biochem Physiol 2015,119,16-27","journal-title":"Pestic Biochem Physiol"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1080\/07391102.2016.1185380","volume":"35","author":"Jacob K.S.","year":"2017","unstructured":"Jacob K.S.; Ganguly S.; Kumar P.;  Homology model, molecular dynamics simulation and novel pyrazole analogs design of Candida albicans CYP450 lanosterol 14 \u03b1-demethylase, a target enzyme for antifungal therapy. J Biomol Struct Dyn 2017,35,1446-1463","journal-title":"J Biomol Struct Dyn"},{"key":"ref=25","first-page":"691","volume":"301","author":"Yang A.S.","year":"2000","unstructured":"Yang A.S.; Honig B.;  An integrated approach to the analysis and modeling of protein sequences and structures. III. A comparative study of sequence conservation in protein structural families using multiple structural alignments1. Biochem Mol Biol J 2000,301,691-711","journal-title":"Biochem Mol Biol J"},{"key":"ref=26","first-page":"85","volume":"12","author":"Rost B.","year":"1999","unstructured":"Rost B.;  Twilight zone of protein sequence alignments. Korean J Chem Eng 1999,12,85-94","journal-title":"Korean J Chem Eng"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1021\/ct050285b","volume":"2","author":"Meyer T.","year":"2006","unstructured":"Meyer T.; Ferrer-Costa C.; P\u00e9rez A.;  Essential dynamics: a tool for efficient trajectory compression and management. J Chem Theory Comput 2006,2,251-258","journal-title":"J Chem Theory Comput"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/prot.22880","volume":"79","author":"Li W.","year":"2011","unstructured":"Li W.; Shen J.; Liu G.;  Exploring coumarin egress channels in human cytochrome P450 2A6 by random acceleration and steered molecular dynamics simulations. Proteins 2011,79,271-281","journal-title":"Proteins"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"10436","DOI":"10.1021\/jp903785h","volume":"113","author":"Shen J.","year":"2009","unstructured":"Shen J.; Li W.; Liu G.;  Computational insights into the mechanism of ligand unbinding and selectivity of estrogen receptors. J Phys Chem B 2009,113,10436-10444","journal-title":"J Phys Chem B"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.cell.2013.01.008","volume":"152","author":"Nygaard R.","year":"2013","unstructured":"Nygaard R.; Zou Y.; Dror R.O.;  The dynamic process of \u03b22-adrenergic receptor activation. Cell 2013,152,532-542","journal-title":"Cell"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nature10867","volume":"482","author":"Kruse A.C.","year":"2012","unstructured":"Kruse A.C.; Hu J.; Pan A.C.;  Structure and dynamics of the M3 muscarinic acetylcholine receptor. Nat 2012,482,552-559","journal-title":"Nat"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1126\/science.1208351","volume":"334","author":"Lindorff-Larsen K.","year":"2011","unstructured":"Lindorff-Larsen K.; Piana S.; Dror R.O.;  How fast-folding proteins fold. Sci 2011,334,517-520","journal-title":"Sci"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"5915","DOI":"10.1073\/pnas.1218321110","volume":"110","author":"Piana S.","year":"2013","unstructured":"Piana S.; Lindorff-Larsen K.; Shaw D.E.;  Atomic-level description of ubiquitin folding. Proc Natl Acad Sci USA 2013,110,5915-5920","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Current Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/172196","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T14:59:49Z","timestamp":1576853989000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/172196\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,2]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,8,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1566524019666190520094644","relation":{},"ISSN":["1566-5240"],"issn-type":[{"value":"1566-5240","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-09-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-24","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-08-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}